|
Dataset ID |
Tissue / Organ |
Experiment type |
Sample |
Cell type |
Marker class |
Evidence |
|
PRJNA656271 (2dpf) |
embryo |
baseline |
2dpf, FACS-isolated EGFP+ cells |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
6dpf, cd41:GFPlow-WT |
Multipotent cells (cluster: 8)
|
potential marker
|
NA
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
10dpf, cd41:GFPlow-runx1-/- |
Erythroid cells (cluster: 4)
|
potential marker
|
NA
|
|
GSE158099 (WT) |
whole body |
baseline |
16dpf, cd41:GFPlow-WT |
Multipotent cells (cluster: 6)
|
potential marker
|
NA
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
HSPCs (cluster: 2)
|
potential marker
|
NA
|
|
PRJNA610520 (3.5dpf) |
caudal hematopoietic tissue |
baseline |
3.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells. |
|
|
|
|
PRJNA610520 (4.5dpf) |
caudal hematopoietic tissue |
baseline |
4.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells. |
|
|
|
|
GSE144944 (fgfr3 +|+) |
cranial vault |
baseline |
1mpf, fgfr3 +/+ |
|
|
|
|
GSE144944 (fgfr3 -|-) |
cranial vault |
growth |
1mpf, fgfr3 -/- |
|
|
|
|
PRJNA734348 (shield, dnmt1) |
embryo |
growth |
6hpf, shield, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV) |
|
|
|
|
PRJNA734348 (dome, control) |
embryo |
baseline |
4.3hpf, dome, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV) |
|
|
|
|
GSE173972 (WT, ezh1+|+) |
embryo |
baseline |
1.25dpf, Kdrl-positive embryos |
|
|
|
|
PRJNA564810 (5dpf) |
embryo |
baseline |
5dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
PRJNA706197 (24hpf) |
embryo |
baseline |
24hpf, FACS sorted sox10:nEOS cells |
|
|
|
|
PRJNA706197 (12hpf) |
embryo |
baseline |
12hpf, FACS sorted sox10:nEOS cells |
|
|
|
|
PRJNA640816 (2dpf) |
embryo |
baseline |
2dpf, FACS isolated -4.9sox10:EGFP+ cells |
|
|
|
|
GSE158849 (unlabeled) |
embryo |
baseline |
6hpf, WT, 4sUTP injected (unlabeled) |
|
|
|
|
PRJNA656271 (24hpf) |
embryo |
baseline |
24hpf, FACS-isolated EGFP+ cells |
|
|
|
|
PRJNA734348 (dome, dnmt1) |
embryo |
growth |
4.3hpf, dome, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV) |
|
|
|
|
GSE173972 (HET, ezh1+|-) |
embryo |
hematopoietic |
1.25dpf, Kdrl-positive embryos |
|
|
|
|
PRJNA706197 (1.25dpf) |
embryo |
baseline |
1.25dpf, FACS sorted sox10:nEOS cells |
|
|
|
|
PRJNA564810 (2dpf) |
embryo |
baseline |
2dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
PRJNA706197 (14hpf) |
embryo |
baseline |
14hpf, FACS sorted sox10:nEOS cells |
|
|
|
|
GSE168695 (5dpf) |
embryo |
baseline |
5dpf, GFP+ cells isolated from 5 dpf cldnb:lyn-EGFP embryos |
|
|
|
|
PRJNA656271 (1.5dpf) |
embryo |
baseline |
1.5dpf, FACS-isolated EGFP+ cells |
|
|
|
|
GSE173972 (KO, ezh1-|-) |
embryo |
hematopoietic |
1.25dpf, Kdrl-positive embryos |
|
|
|
|
PRJNA734348 (shield, control) |
embryo |
baseline |
6hpf, shield, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV) |
|
|
|
|
PRJNA564810 (1dpf) |
embryo |
baseline |
1dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
PRJNA706197 (18hpf) |
embryo |
baseline |
18hpf, FACS sorted sox10:nEOS cells |
|
|
|
|
PRJNA706197 (20hpf) |
embryo |
baseline |
20hpf, FACS sorted sox10:nEOS cells |
|
|
|
|
GSE158849 (labeled) |
embryo |
baseline |
6hpf, WT, 4sUTP injected (labeled) |
|
|
|
|
GSE161712 (M. marinum) |
granulomas |
disease |
adult, infected with bacteria of M. marinum |
|
|
|
|
PRJNA608912 (kit_2dpi) |
heart |
regeneration |
5mpf, kit mutant, 2 days post injury |
|
|
|
|
PRJNA605021 (supporting cells) |
neuromast |
baseline |
7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[Et(krt4:EGFP)sqgw57A] transgenic zebrafish larvae |
|
|
|
|
PRJNA605021 (hair cells) |
neuromast |
baseline |
7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[myo6b:actb1-EGFP] transgenic zebrafish larvae |
|
|
|
|
PRJNA668529 (3d) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 days |
|
|
|
|
PRJNA668529 (3h) |
olfactory rosette |
disease |
3mpf, intranasal 100ng r-Spike 3 hours |
|
|
|
|
PRJNA668529 (control) |
olfactory rosette |
baseline |
3mpf, intranasal PBS |
|
|
|
|
GSE148591 (3mpf) |
pituitary |
transplant |
3mpf, graft transplantation during early embryogenesis |
|
|
|
|
PRJNA551501 (2mpf) |
thyroid gland |
baseline |
2mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
PRJNA551501 (8mpf) |
thyroid gland |
baseline |
8mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
GSE152982 (wild type) |
trunk |
baseline |
1.25dpf, untreatment |
|
|
|
|
GSE163907 (24hpf) |
trunk |
baseline |
24hpf, trunk tg(sox10:GFP) positive cells |
|
|
|
|
GSE131136 (all) |
trunk, skin |
baseline |
5dpf, sox10:CRE positive cells from 5dpf and post-embryonic zebrafish trunks with and without thyroid hormone |
|
|
|
|
PRJNA641144 (M_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo metastases |
|
|
|
|
PRJNA641144 (M_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vivo metastases |
|
|
|
|
GSE176129 (pdgfrb-positive) |
whole body |
baseline |
5dpf, FACS-isolated pdgfrb-positive cells |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
6dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
10dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
: marker.